Intra-Cellular Therapies Inc (NASDAQ:ITCI)

52.62
Delayed Data
As of 3:59pm ET
 -1.82 / -3.34%
Today’s Change
42.01
Today|||52-Week Range
67.05
-0.57%
Year-to-Date

Today’s Trading

Previous close54.44
Today’s open53.96
Day’s range52.62 - 54.07
Volume27,015
Average volume (3 months)646,610
Market cap$5.3B
Data as of 3:59pm ET, 09/21/2023

Growth & Valuation

Earnings growth (last year)+22.08%
Earnings growth (this year)+15.94%
Earnings growth (next 5 years)+98.10%
Revenue growth (last year)+198.69%
P/E ratioNM
Price/Sales19.88
Price/Book7.95

Competitors

 Today’s
change
Today’s
% change
DCHPFDechra Pharmaceutica...0.000.00%
----
ALKSAlkermes Plc-0.44-1.46%
----
Data as of 4:00pm ET, 09/21/2023

Financials

Next reporting dateNovember 7, 2023
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$250.3M
Annual profit (last year)-$256.3M
Net profit margin-102.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts